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1. Introduction 
In the retina, as in other parts of the central nervous system, excitatory synaptic 
transmission is mediated by glutamate. Excitatory synaptic transmission begins typically 
with a depolarization of the presynaptic (axon) terminal membrane resulting in an influx of 
calcium ions from the extracellular space into the presynaptic terminal. This influx of 
calcium ions triggers release of glutamate from the presynaptic terminal into the synaptic 
cleft. Glutamate then diffuses across the synaptic cleft and binds to ion channels of the post-
synaptic membrane (neuronal dendrite). These glutamate-gated channels allow sodium and 
calcium ions to flow from the extracellular space into the post-synaptic dendritic 
compartment, thereby depolarizing or "exciting" the post-synaptic neuronal membrane. In 
order to preserve both the temporal properties and local specificity of synaptic transmission, 
glutamate must be cleared rapidly from the extracellular space by transporters located in 
neurons as well as glial cells. 
It has been shown that excessive levels of excitatory activity can result in excitotoxic neuronal 
injury that is mediated ultimately by elevation of intracellular sodium and calcium 
concentration. Excitotoxic neuronal injury can be triggered by a wide range of primary 
insults and associated mechanisms that vary with location within the neuronal membrane 
compartment. In retinal ganglion cells (RGCs), somato-dendritic membrane is specialized 
for receiving synaptic inputs and integrating those conductance changes while axonal 
membrane is specialized for transmission of action potentials and synaptic communication. 
RGC dendritic membrane thus has a high density of glutamate-gated channels (Aizenman et 
al., 1988; Massey & Miller, 1990; Diamond & Copenhagen, 1993) while the axonal membrane 
has a high density of voltage-gated sodium channels (Pellegrino & Ritchie, 1984; Craner et 
al., 2003). RGC axons are not known to express glutamatergic channels but voltage-gated 
sodium channels are also expressed in somato-dendritic membrane (Wollner et al., 1988; 
Kaneda & Kaneko, 1991). Excessive activation of either glutamate-gated channels or voltage-
gated sodium channels can result in excitotoxic injury to RGCs. Although other membrane 
conductances may, under some circumstances, drive excitotoxic RGC injury, this chapter 
will focus on mechanisms for RGC injury resulting from glutamate-gated channels and 
voltage-gated sodium channels.  
2. Glutamatergic excitotoxicity  
There are two general classes of glutamate-gated ion channel in the CNS: the NMDA-type 
and the non-NMDA type (Choi, 1988; Schoepfer et al., 1994). For both classes, glutamate is  
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the normal endogenous ligand for channel activation but they may be distinguished by their 
selectivity for molecules that can bind to and activate the channel. NMDA-type channels are 
activated selectively by N-methyl-D-aspartate while non-NMDA channels are activated 
selectively by either kainate or ǂ-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid 
(AMPA). Both sub-types are permeable to sodium and calcium ions and neurons may be 
injured by excessive activity of either subtype. However, due to the relatively high calcium 
permeability of NMDA-type channels, neurons are particularly sensitive to injury resulting 
from overactivity of this channel subtype (Rothman & Olney, 1987). RGCs are known to 
express NMDA-type channels and glutamatergic excitotoxicity, mediated by NMDA 
channels , has been shown to be an important mechanism for RGC injury in a wide range of 
animal models for both acute and chronic disease including retinal ischemia (Lam et al., 
1997; Lagreze et al., 1998), and glaucoma (Gu et al., 2000; WoldeMussie et al., 2002; 
Schuettauf et al., 2002; Hare et al., 2004a, 2004b).  
Some key features of NMDA channel function are summarized in Figure 1. Under "resting" 
conditions, the trans-membrane potential is highly negative and the channel conductance 
gate is closed (A). At this high negative "resting" membrane potential, a magnesium ion is 
bound to a site within the channel conductance pore. When glutamate (or NMDA) binds to 
its receptor site, the channel opens but cannot conduct sodium or calcium ions due to block 
of the channel pore by magnesium (B). Unbinding of magnesium from its site within the 
pore requires depolarization of the neuronal membrane. That is, the probability of 
magnesium binding decreases with decreasing membrane polarization (C). The NMDA 
channel thus acts as a coincidence detector or, in the parlance of digital logic, an "AND" 
gate. In other words, the NMDA channel requires the simultaneous activity of non-NMDA 
channel synaptic input (or some other depolarizing event) in order to be "active", regardless 
of whether or not the channel has been "opened" by glutamate binding.  
Any insult or condition that leads either to an increase in extracellular levels of glutamate or 
to an increase in the effect of glutamate at the post-synaptic membrane may trigger 
excitiotoxic neuronal injury. Ischemic insult provides one example for excitotoxic neuronal 
injury. Under conditions of metabolic insufficiency, cellular energy failure will be associated 
with loss of function in energy-dependent membrane transporters. Failure of the 
sodium/potassium exchanger results in loss of the transmembrane sodium gradient and 
depolarization of the "resting" membrane potential. Membrane dopolarization, in turn, 
increases the release of glutamate from presynaptic terminals and also decreases the 
voltage-dependent magnesium block of NMDA channel pores in the post-synaptic 
membrane. The resulting increase in glutamate-gated influx of sodium and calcium ions 
further depolarizes the cell membrane and also leads directly to cell injury through 
activation of calcium-dependent mechanisms as well as loss of function in membrane 
transporters that rely on the trans-membrane sodium gradient.  
2.1 Glutamatergic excitotoxicity in RGCs  
Glutamatergic neuronal excitotoxicity, originally described in the retina (Lucas & 
Newhouse, 1957), results from excessive activity of glutamate-gated ion channels and 
consequent increase in the intracellular levels of both sodium and calcium ions. RGCs are 
known to express both NMDA and non-NMDA type glutamataergic channels and are 
sensitive to injury from exposure to exogenously applied NMDA (Siliprandi et al., 1992; 
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Pellegrini & Lipton, 1993; Pang et al., 1999; Luo et al., 2001). In addition, systemic treatment 
with selective NMDA antagonists has shown that NMDA-type glutamatergic membrane 
channels make a significant contribution to RGC injury in rat (Gu et al., 2000; WoldeMussie 
et al., 2002) and monkey (Hare et al., 2004a, 2004b) models of experimental glaucoma. 
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Fig. 1. Function of the NMDA-type glutamate-gated channel. Channel opening (B) requires 
binding of both glutamate (Glut) and glycine (not shown). See also (Choi, 1988) 
Acute glutamatergic excitotoxic responses can be observed in electrophysiological recordings 
from single RGCs in a dark-adapted, perfused, ex-vivo rabbit retina preparation as illustrated 
in Figure 2. For these experiments, simultaneous recordings of the electroretinogram (ERG) 
and single-unit RGC responses were made. The retinal sample, beginning at the inferior 
margin of the optic disk as shown in panel A, was mounted RGC (vitreal) side up in the 
perfusion chamber as shown in panel B. The transretinal potential (ERG) was recorded as 
the voltage between the bath electrode and the sub-retinal electrode. The spiking activity of 
a single RGC was recorded using a tungsten microelectrode and the bath electrode as 
reference. Dim stimuli (delay = 400 msec, duration = 10 msec) were generated using a blue-
green LED (λpeak = 504 nM). RGCs were classified as either "ON" or "OFF" subtype based 
on the response to a dim stimulus of one second duration. ON RGCs respond to this 
stimulus with a burst of action potentials at the stimulus onset while OFF RGCs are 
inhibited by the stimulus and respond with a burst of action potentials at stimulus offset 
(not shown). 
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Fig. 2. Ex-vivo dark-adapted perfused rabbit retina preparation for simultaneous recording 
of the ERG and single-unit RGC activity. RGCs were classified as either "ON" or "OFF" 
subtype 
Figure 3A shows the ERG (top trace) and single-unit RGC (bottom trace) responses to a dim 
flash delivered at 400 msec (vertical line). Note that the dim flash is below the ERG a-wave 
threshold and elicits a purely b-wave response. This OFF RGC exhibits a tonic level of 
spiking activity and responds to the dim flash with a burst of spikes at a latency of 
approximately 100 msec. At 2 minutes following continuous bath application of 200 µM 
NMDA (panel B), there is an obvious increase in the tonic level of RGC spiking activity, a 
reduction in spike amplitude, and no significant effect on the ERG. After 6 minutes of 
NMDA exposure (panel C), the RGC spike generation mechanism has failed. At 2 minutes 
following the switch to perfusion with 200 µM NMDA in combination with 10 µM 
memantine (a selective NMDA channel blocker), the RGC spike generation mechanism has  
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begun to recover. The RGC has recovered to CONTROL levels of tonic spike frequency and 
amplitude by 4 minutes following addition of memantine. Clearly, application of exogenous 
NMDA results in an increase in tonic RGC spiking activity with a consequent rundown of 
the trans-membrane sodium gradient and loss of spike generation. Addition of memantine 
is able to completely reverse the effects of continuously applied NMDA and restore normal 
levels of tonic spike activity including responses to light stimuli. 
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Fig. 3. Exogenous application of NMDA results in excitotoxicity in an OFF RGC that is 
reversed by co-application of memantine, an uncompetitive NMDA open-channel blocker. 
In all panels: top trace = ERG, bottom trace = single-unit RGC spikes. 10 msec duration 
stimulus flash onset at 400 msec (vertical line). ERG = microvolts. RGC = millivolts. (From 
Hare & Wheeler 2009) 
Memantine is an "open channel blocker" of the NMDA channel pore (Pelligrini et al., 1992; 
Chen & Lipton, 1997). In order for memantine to access its binding site within the pore, 
the channel must be in the open configuration following binding of glutamate (or NMDA) 
and magnesium must unbind from its site within the pore (see Figure 1). These properties 
of memantine binding make it more effective to block very high (pathological) levels of 
NMDA receptor activity while having a lesser effect on lower (normal) levels of activity. 
Figure 4 summarizes results which show that application of NMDA to a different OFF 
RGC has a similar effect to increase tonic RGC spiking frequency and to reduce spike 
amplitude. In this case, NMDA-induced excitotoxic RGC activity was reversed completely 
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by co-application of 30 µM AP5 (2-amino-5-phosphonovaleric acid). Unlike memantine, 
AP5 competes with glutamate (or NMDA) for its binding site on the NMDA receptor to 
block channel opening. 
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Fig. 4. NMDA-induced excitotoxicity in an OFF RGC is completely reversed by co-
application of AP5, a competitive NMDA receptor antagonist. (From Hare & Wheeler, 2009) 
Exogenous application of NMDA mimics the pathological condition where excessive release 
of glutamate into the extracellular space results in excitotoxic activity of NMDA receptors. 
Increased release of glutamate into the extracellular space has been reported in various 
models for experimental insults to CNS tissue including retina (Louzada-Junior et al., 1992; 
Neal et al., 1994; Kowluru et al., 2001; Nucci et al., 2005). RGCs are much less sensitive to 
exogenously applied glutamate since CNS tissue expresses high levels of glutamate 
transporters that, under normal conditions, provide for very tight regulation of extracellular 
glutamate levels. These transporters work to prevent exogenously applied glutamate from 
reaching increased levels at the post-synaptic membrane receptors. RGCs are much more 
sensitive to exogenously applied NMDA since it is not transported by these intrinsic 
glutamate buffer mechanisms. Under pathological conditions, failure of these glutamate 
transporters would be expected to contribute to elevations in extracellular glutamate that 
could drive excitotoxic RGC injury. For this reason, a different series of experiments used 
exogenous application of TBOA (DL-threo-ǃ-benzyloxyaspartic acid) to block selectively 
retinal glutamate transporters (Izumi et al., 2002). Figure 5 shows that application of 50 µM 
TBOA was associated with a rapid increase in tonic spiking of this OFF RGC and reduction 
of spike amplitude (panel B) followed by complete block of RGC spike generation (panel C). 
As was seen for reversal of NMDA-induced excitotoxicity, co-application of memantine 
produced a rapid recovery of both spike amplitude and tonic spike frequency toward 
control levels (panel D). Memantine washout in the presence of continuous application of 
TBOA was associated with the reappearance of excitotoxic RGC spiking activity (panel E). 
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Fig. 5. For this OFF RGC, block of retinal glutamate transporters with TBOA results in 
excitotoxic activity that can be reversed by co-application of memantine. (From Hare & 
Wheeler, 2009) 
Membrane depolarization resulting from cellular energy failure or other causes is thought to 
play an important role in excitotoxic neuronal injury. Membrane depolarization is 
associated with decreased binding of magnesium at its blocking site within the NMDA 
channel pore (see Fig. 1). For this reason, when RGCs become chronically depolarized, 
excitotoxic levels of NMDA channel activity can occur even in the presence of otherwise 
"normal" levels of extrtacellular glutamate (Zeevalk & Nicklas, 1992). The loss of voltage-
dependent magnesium block can be experimentally approximated by perfusion with 
magnesium-free solution. The results for the ON RGC summarized in Figure 6 show that the 
switch to zero magnesium solution was followed by an increased rate of spiking activity 
and reduction of spike amplitude (panel C). This excitotoxic response is similar to that seen 
following perfusion with either NMDA (see Fig. 3) or TBOA (see4 Fig. 5) and was also 
reversed by co-application of memantine (panel D). However, the decrease in spike 
amplitude (spike generation failure) seen in zero magnesium typically developed more 
slowly than spike generation loss resulting from either NMDA or TBOA. 
2.2 Regulation of NMDA receptor function in RGCs 
We have seen how the level of NMDA receptor activity in RGCs depends upon the amount 
of glutamate released from pre-synaptic neurons, the removal of glutamate from the 
extracellular space by glutamate transporters, and the degree of voltage-dependent 
magnesium block set by the RGC membrane potential. It has also been shown recently that 
activation of alpha-2 adrenergic receptors reduces NMDA-induced responses in RGCs. This 
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Fig. 6. Perfusion with zero magnesium results, for this ON RGC, in excitotocic activity that 
resembles that seen following application of either NMDA or TBOA and is also reversed by 
co-application of memantine. (From Hare & Wheeler, 2009) 
finding results from studies using simultaneous recordings of the membrane current and 
cytoplasmic calcium concentration changes induced by application of NMDA. For these 
experiments, whole-cell current recordings were made from RGCs in a flat-mounted, 
perfused, ex-vivo rat retina preparation as illustrated schematically in Figure 7. For these 
recordings, the RGC membrane is voltage-clamped at -70 mV, close to the normal "resting" 
level. The recording pipette contained the calcium indicator Fluo-4 which was passively 
loaded into the RGC cytoplasm through diffusion. Activation of NMDA receptors was 
effected using local delivery of NMDA. RGC membrane current was measured using 
conventional voltage-clamp methods while cytoplasmic calcium measures were acquired 
with a spinning disk confocal fluorescence imaging system.  
Results from one experiment are summarized in Figure 8 where the top panel traces 
represent recordings of RGC membrane current responses to local NMDA application 
(heavy black horizontal bar) and the bottom panel traces represent changes in cytoplasmic 
calcium concentration to the same NMDA applications. Note that under control conditions 
(red traces), NMDA induces an inward current representing an influx of sodium and 
calcium cations while this inward calcium flux produces an increase in cytoplasmic calcium. 
Continuous bath application of 10 µM memantine is associated with a severe reduction in 
NMDA-induced membrane current and cytoplasmic calcium signal (green traces). This 
effect of memantine is rapidly reversed following washout (blue traces). 
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Fig. 7. Simultaneous measures of membrane current and cytoplasmic calcium level in a 
single RGC in the flat-mounted, perfused, ex-vivo rat retina. NFL (nerve fiber layer), GCL 
(ganglion cell layer), IPL (inner plexiform layer), INL (inner nuclear layer) 
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Fig. 8. NMDA-induced membrane current (upper panel) and cytoplasmic calcium signal 
(lower panel) in a single RGC are reduced by bath application of memantine 
Recordings from a different RGC are summarized in Figure 9. The traces in panel A show 
that bath application of 3 µM brimonidine, a selective alpha-2 adrenergic receptor agonist, is 
associated with a reduction of both the NMDA-induced current and calcium signals by 
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approximately 40% and 50%, respectively. The summary results plotted in panel C show 
that this effect of brimonidine to reduce NMDA-induced current and calcium signals is 
blocked by co-application of 15 µM atipamezole (a selective alpha-2 receptor antagonist) or 
by intracellular loading (via the patch pipette) of GDPǃS, a G-protein inhibitor. These 
findings are consistent with the notion that alpha-2 receptor activation, through Gαi – 
mediated coupling, leads to inhibition of adenyl cylase and a consequent decline in 
cytoplasmic levels of cyclic AMP. In other experiments, intracellular application of Sp-
cAMPS, a hydrolysis-resistant analog of cAMP, was also shown to block the effect of 
brimonidine to decrease NMDA-induced current and calcium signals (data not shown). 
Further confirmation that activation of alpha-2 receptors leads to a down regulation of 
NMDA receptor activity by reducing intracellular levels of cAMP is provided by results 
summarized in Figure 10. Intracellular application of either rolipram, a selective PDE4 
inhibitor, or forskolin, an activator of adenyl cyclase, resulted in a block of the brimonidine 
effect. 
 
 
Fig. 9. Bath application of brimonidine reduces the magnitude of NMDA-induced current 
and calcium responses in RGCs. This effect is blocked by either an alpha-2 receptor 
antagonist (atipamezole; bath application) or G protein inhibitor (GDPǃS; intracellular 
application). The yellow windows in panel B indicate RGC region used for calcium 
measures. (From Dong et al., 2008) 
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Fig. 10. Intracellular application of either rolipram (PDE4 inhibitor) or forskolin (adenyl 
cyclase activator) results in block of the brimonidine effect on NMDA-induced current or 
calcium responses in RGCs. (From Dong et al., 2008) 
Results from recordings of NMDA-induced RGC responses in an ex-vivo rat retina thus 
show that NMDA channel function and, by extension, intracellular calcium concentration 
are regulated by apha-2 adrenergic receptors through Gǂi–coupled inhibition of adenyl 
cyclase. Brimonidine treatment has been shown to prevent damage in a wide range of 
animal models for RGC injury including experimental glaucoma (WoldeMussie et al., 2001; 
Kim et al., 2007), acute retinal ischemia (Donello et al., 2001; Lafuente et al., 2002; Lai et al., 
2002), optic nerve mechanical injury (Yoles et al., 1999; Ma et al., 2009), and NMDA-induced 
retinal excitotoxicity (Metoki et al., 2005; Dong et al., 2008); all models in which NMDA 
receptors have been shown to play a significant role in driving RGC injury. Two of these, a 
rat model for experimental glaucoma and a rabbit model for intravitreal injection of NMDA, 
were used to demonstrate that the protective effects of brimonidine treatment result from 
alpha-2 receptor mediated inhibition of adenyl cyclase activity. 
Figure 11 shows that, for the rat glaucoma model used in this study, laser photocoagulation 
of the perilimbal vessels and episceral veins was followed, on average, by an increase in 
intraocular pressure (IOP) from a control level of approximately 15 mm Hg to 
approximately 30 mm Hg. RGC survival was quantified, at approximately 2 weeks 
following IOP elevation, by flat-mounting the retina and counting RGCs at 24 locations in 
the central and peripheral retina (panel A). RGCs were labeled using retrograde transport of 
rhrodamine-conjugated dextran delivered directly to the retrobulbar optic nerve (panel B). 
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Untreated (control) glaucoma eyes lost, on average, approximately 30 % of their RGCs 
(panel C). Continuous dosing, using subcutaneous osmotic pumps, with either memantine 
(3 mg/kg/day) or brimonidine (0.18 mg/kg/day) resulted in a reduction of RGC loss to less 
than 10%. This protective effect of brimonidine was blocked by co-administration of either 
the selective PDE4 inhibitor, rolipram (0.6 mg/kg/day), or the selective alpha-2 receptor 
antagonist, atipamezole (0.9 mg/kg/day). None of these systemically delivered test agents 
had any significant effect on IOP in the laser treated eye (panel E). 
 
 
Fig. 11. Treatment with either memantine or brimonidine is associated with a reduction in 
the level of RGC loss in a rat model of experimental glaucoma. The protective effect of 
brimonidine treatment is blocked by co-administration of either an alpha-2 receptor 
antagonist (atipamezole) or an inhibitor of PDE4 (rolipram). (From Dong et al., 2008) 
Intravitreal injection of NMDA is known to be toxic to RGCs and provides a model of RGC 
injury that has, as its primary insult, the overactivity of NMDA receptors. As shown in 
Figure 12, RGC injury following injection of NMDA into the rabbit eye was quantified by 
counting DAPI-labeled cells in the RGC layer. RGC layer cells (RGCs & displaced amacrine 
cells) were counted in a 5x5 sampling array whose superior row included the visual streak 
(region of highest RGC density; panelA). Intravitreal injection of 50 µL saline solution 
containing 3.6 micromoles of NMDA resulted in the loss, at two weeks following NMDA 
injection, of approximately 40 % of DAPI-labeled cells in the RGC layer (panel D). Co-
www.intechopen.com
 Excitotoxic Injury to Retinal Ganglion Cells 
 
125 
injection of two different NMDA channel blockers, either MK-801 (0.12 micromoles) or 
memantine ( 0.36 micromoles), reduced loss to either approximately 0% or approximately 
10%, respectively. Co-injection of brimonidine (3.6 nanomoles) also reduced NMDA-
induced RGC loss to approximately 20% and this protection was blocked by co-injection of 
the combination of either brimonidine + atipamezole (24.0 nanomoles) or brimonidine + 
rolipram (12-120 nanomoles). While total RGC counts are plotted in panel D, averaged 
counts for each of the 25 sample regions from a representative animal are plotted in panel C 
for each treatment group. 
 
 
Fig. 12. Intravitreal injection of NMDA results in excitotoxic RGC loss that can be prevented 
or reduced with co-injection of either an NMDA channel blocker (MK-801 or memantine) or 
an alpha-2 receptor agonist (brimonidine). The protective effect of brimonidine is, in turn, 
blocked by co-injection of brimonidine in combination with a selective alpha-2 receptor 
antagonist (atipamezole) or by co-injection of brimonidine in combination with a PDE4 
inhibitor (rolipram). (From Dong et al., 2008) 
These results show clearly that RGC injury in both the rat model for experimental glaucoma 
and the rabbit model for NMDA-induced excitotoxicity is driven predominantly by 
overactivity in NMDA-type glutamate-gated channels. Treatment with either MK-801 or 
memantine reduces RGC injury by blocking directly the conductance pore of the NMDA 
channels, thereby reducing NMDA-induced increases in sodium and calcium ions. 
Brimonidine treatment reduces NMDA channel activity indirectly through a mechanism 
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that includes alpha-2 receptor activation, inhibition of adenyl cyclase, and decreased levels 
of intracellular cAMP. Pharmacological agents that act to block brimonidine-elicited 
decreases in cytoplasmic cAMP also block brimonidine's action to decrease NMDA-induced 
currents and calcium signals in RGCs. These same agents block the protective effects of 
brimonidine treatment in animal models of RGC injury known to be driven predominantly 
by overactivity in NMDA channels.  
3. Excitotoxicity and voltage-gated sodium channels 
Visual signals are transmitted from the retina to more central visual pathways via the RGC 
axons. Signal transmission is coded as a temporal pattern of "spikes" or "action potentials"; 
each spike consisting of a regenerative depolarizing (inward) membrane current that 
typically travels from its generation site at the RGC soma (axon hillock) to the axon terminal 
in the brainstem. Axon spikes reflect the activity of voltage-gated sodium channels. At high 
negative resting potentials (inside negative trans-membrane voltage), these sodium channels 
are closed. Decreasing the membrane voltage (depolarization = decreased inside negative) 
activates the channels and allows sodium ions to flow down their electrochemical gradient 
from the extracellular space into the axonal cytoplasm. This influx of sodium ions represents 
an inward current that spreads passively to depolarize and activate sodium channels in the 
immediately neighboring (resting) axonal membrane. In this manner, local inward current, 
generated by voltage-gated sodium channels, propagates along the axon in a regenerative 
fashion and transmits a wave of membrane depolarization to the axon terminal. Good 
temporal bandwidth for information transfer requires that these individual spike events be 
of very short duration. For this reason, following activation by membrane depolarization, 
voltage-gated sodium channels typically inactivate rapidly in a time-dependent fashion in 
order to move axonal membrane voltage back toward the resting level. That is, sodium 
channels are activated by membrane depolarization but rapidly inactivate, even in the 
presence of continued membrane depolarization. This property of the sodium channels is 
responsible for the fact that spikes are able to travel only in one direction: away from 
immediately active membrane and toward membrane that is "at rest". Membrane 
depolarization not only activates sodium channels but also inactivates them and the 
channels remain inactivated until membrane potential is returned toward the resting level. 
Action potential generation is thus dependent upon both the sodium gradient as well as 
membrane voltage. The resting transmembrane sodium gradient (intracellular concentration 
= low, extracellular concentration = high) is generated by energy-dependent pumps that 
move sodium from the cytoplasm to the extracellular space. The same pumps contribute to 
both the electrical and chemical transmembrane gradient for sodium ions. The 
transmembrane sodium gradient provides an electrochemical energy source that is used by 
a wide range of membrane transporters including the sodium/calcium exchanger (SCE). 
The SCE uses energy available from sodium ions moving down their electrochemical 
gradient to transport calcium ions from the cytoplasm to the extracellular space; against 
both the electrical (inside negative) and chemical (calcium inside is low) gradient for 
calcium ions. Calcium is an important regulator of many intracellular signaling pathways 
and its cytoplasmic concentration is very tightly regulated at levels typically lower than a 
resting level of 200 nM (Connor & Tseng, 1988; Kirischuk et al., 1992). Even small prolonged 
elevations above this level can result in irreversible injury to RGCs. Any condition resulting 
in a loss of the electrochemical gradient for sodium ions will also be associated with, among 
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other things, depolarization of the axonal membrane and increases in the cytoplasmic 
concentration of calcium ions. 
Although the mechanisms for glaucomatous RGC injury are not known, evidence suggests 
that a primary insult to RGC axons at or near the optic nerve head may be a significant 
contributor to glaucomatous vision loss (Quigley et al., 1981; Johansson, 1986). It has been 
proposed that IOP can generate mechanical forces at or near the lamina cribrosa resulting in 
direct injury to RGC axons. These same IOP-induced stresses will compromise local vascular 
perfusion of the tissue resulting indirectly in ischemic insult of RGC axons (Burgoyne & 
Downs, 2008). Mechanisms for ischemic injury to RGC axons have been explored using an 
isolated perfused rat optic nerve preparation in combination with methods for induction of 
experimental ischemia. For these studies, optic nerves were isolated (from eye to chiasm) 
from adult rats and mounted in a perfusion chamber between two suction electrodes as 
shown in Figure 13. Nerves were maintained at 370 C and perfused with bicarbonate 
buffered ringer saturated with 95% O2 and 5% CO2. At one end of the nerve, a constant 
voltage pulse of 50 µsec duration was used to drive depolarizing current through the tissue 
to bath ground. This current, if strong enough to reach threshold depolarization for axonal 
membrane sodium channels, initiates in each axon a spike that travels to the opposite end 
where it can be measured as a voltage. Since each axon can generate only a single spike in 
response to the brief stimulus pulse, the resulting composite voltage signal represents the 
temporal sum of all such single spikes generated in all activated axons. This composite 
response is therefore referred to as the compound action potential (CAP). 
 
 
Fig. 13. Recording of the compound action potential (CAP) from the isolated rat optic nerve. 
(From Dong & Hare 2005) 
The two panels in Figure 14 illustrate how the CAP varies with stimulus intensity. The 
family of traces in panel A shows how the CAP response increases in magnitude with 
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increasing stimulus voltage. That is, increasing stimulus intensity is associated with an 
increasing number of activated axons. The CAP waveform also clearly represents three 
functionally distinct axonal populations having different conduction velocities. Although, 
for these short conduction lengths, there is considerable temporal overlap of the three spike 
populations, it can be seen that the fastest spikes (large neurons, large axons) have the 
lowest stimulus voltage activation threshold while the slowest spikes (small RGCs, small 
axons) have the highest threshold. Due to the temporal overlap of spikes from the three 
different groups of axons, integrated CAP response area was measured instead of peak 
amplitude as indicated in panel B. Panel B also shows that CAP amplitude (area) saturated 
at a stimulus intensity of approximately 150 volts which was used for all subsequent 
experiments since this intensity is expected to activate all functional axons. 
 
 
Fig. 14. CAP response as a function of stimulus intensity (voltage). Response amplitude is 
measured as the area of the CAP response. (From Dong & Hare, 2005) 
Experimental ischemia was induced by switching to a perfusion medium which was 
saturated with nitrogen instead of oxygen and from which glucose was omitted (oxygen-
glucose deprivation; OGD). Figure 15 shows that, following the switch to OGD, CAP 
amplitude declined rapidly and was almost completely blocked after 60 minutes of OGD. 
The switch back to control saline was associated with a partial recovery of the CAP 
response. This recovery was typically stable by 20 minutes following OGD washout. 
Responses obtained prior to OGD (1), at the end of 60 minutes OGD (2), and at 60 minutes 
following switch back to control saline (3), are illustrated in panel B. The inset in panel A 
also shows how CAP amplitude following recovery from OGD is dependent upon the 
duration of OGD. A standard OGD duration of 60 minutes was used for the experiments 
described here. 
Experimental ischemia (OGD) of 60 minutes duration is associated with approximately a 
70% irreversible loss of axonal function resulting from a failure of the membrane machinery 
responsible for spike generation and propagation. This injury results, in turn, from loss of 
the transmembrane sodium gradient and the subsequent elevation of intracellular calcium. 
According to this model, axonal energy failure leads to loss of energy-dependent sodium 
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extrusion with consequent loss of the trans-membrane sodium gradient and resting 
membrane potential. Under these conditions, axonal sodium gradient and membrane 
voltage are further reduced due to influx of sodium ions through voltage-gated sodium 
channels. Although most membrane sodium channels are inactivated by membrane 
depolarization, a subset of these channels remains open and contributes to loss of the 
sodium gradient (Stys et al., 1993; Hammarstrom & Gage, 2002). Since intracellular calcium 
is normally regulated at very low intracellular levels by the action of a calcium extrusion 
mechanism (sodium/calcium exchanger), the loss of the membrane sodium gradient results 
in elevation of intracellular calcium and activation of calcium-dependent mechanisms for 
axonal injury (Stys et al., 1992; Garthwaite et al., 1999). 
 
 
Fig. 15. OGD of 60 minutes duration is associated with irreversible loss of function in 
isolated rat optic nerve. (From Dong & Hare, 2005) 
The dependence of OGD-induced axonal injury on the influx of sodium ions through non-
inactivating voltage-gated sodium channels is illustrated by results summarized in Figure 
16. Results from the control experiments of Figure 15 are re-plotted as the filled black 
squares in panel A. Nerves exposed to bath application of 1 mM lidocaine (open squares), a 
sodium channel blocker, for 20 minutes prior to OGD as well as during the 60 minute 
exposure to OGD, recovered a greater level of function (CAP area) than untreated nerves. 
Inspection of panel A shows that pre-treatment with lidocaine is associated with complete 
block of the CAP by the onset of OGD. At the end of OGD, lidocaine must wash out before 
any protective effect can be measured. These results show clearly that OGD-induced axonal 
injury is mediated, at least in part, by sodium influx via voltage-gated sodium channels. 
This was further tested in experiments where the nerves were perfused with sodium-free 
medium for 20 minutes prior to and during OGD as summarized in Figure 17. The open 
squares plotted in panel A show that removal of sodium ions from the extracellular space 
reduces axonal functional loss associated with OGD; supporting the notion that injury 
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depends significantly on the net flux of sodium ions from the extracellular space to the 
axonal cytoplasm. 
 
 
Fig. 16. Blockade of voltage-gated sodium channels with bath application of 1 mM lidocaine 
(for 20 minutes preceding OGD and during OGD) reduces OGD-induced axonal injury. 
(From Dong & Hare, 2005) 
Removal of calcium from the perfusion medium is also associated with a reduction of OGD-
induced axonal injury. Figure 18 shows that perfusion with zero-calcium medium for 20 
minutes before as well as during OGD resulted in a reduction of OGD-induced axonal 
injury. Results from experiments using either a sodium channel blocker (lidocaine; Figure 
16), zero sodium medium (Figure 17), or zero calcium medium (Figure 18) are summarized 
for comparison in Figure 19. Prevention of sodium overload is clearly associated with 
reduced OGD-induced axonal injury. The fact that perfusion with zero calcium medium, in 
the presence of normal extracellular sodium levels and functioning voltage-gated sodium 
channels, is able to reduce axonal injury suggests that increased intracellular calcium is the 
major driver of injury and that intracellular sodium overload leads to injury, in large part, 
by reducing extrusion of axonal calcium by the sodium/calcium exchanger. In fact, if the 
sodium gradient and membrane potential are decreased sufficiently, the exchanger can run 
in reverse mode to actually transport calcium into the cell and further accelerate increases in 
intracellular calcium. 
These experiments show how intracellular sodium overload, by reducing calcium extrusion 
via the sodium/calcium exchanger, leads to injury of RGC axons indirectly through the 
elevation of intracellular calcium. Of course, sodium overload may also contribute to axonal 
injury resulting from loss of function in other sodium-dependent membrane transporters 
that, in addition to the sodium/calcium exchanger, are also necessary for axonal 
function/survival. For this model of acute experimental ischemic insult axonal injury is 
driven predominantly by failure of membrane calcium transport. Voltage gated sodium 
channels are also found in somato-dendritic RGC membrane where the sodium/calcium 
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Fig. 17. Removal of sodium ions from the extracellular space (perfusion with zero sodium 
medium), both prior to and during OGD, reduces OGD-induced axonal injury. For zero 
sodium medium, sodium chloride was replaced with lithium chloride and sodium 
bicarbonate was replaced with choline bicarbonate. (From Dong & Hare, 2005) 
 
 
Fig. 18. Perfusion with zero-calcium medium is associated with a reduction of OGD-induced 
axonal injury. Calcium was omitted from the medium and replaced with 5 mM EGTA 
(calcium buffer). (From Dong & Hare, 2005) 
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exchanger is also an important mechanism for regulation of intracellular calcium at low 
levels. However, models of injury to the somato-dendritic compartment are complicated by 
the fact that glutamate-gated channels and voltage-gated calcium channels provide 
additional sources for entry of sodium and calcium ions that also contribute to RGC injury. 
 
 
Fig. 19. Summary of results for experiments showing that blockade of sodium channels 
(Lido), perfusion with zero-sodium medium (0 Na+), or perfusion with zero-calcium 
medium (0 Ca++) is associated with a reduction in OGD-induced axonal injury. (From Dong 
& Hare, 2005) 
4. Conclusion  
Although the precise mechanism for glaucomatous injury to RGCs is not known, glutamate-
gated ion channels and voltage-gated sodium channels are known to contribute to RGC 
injury resulting from a wide range of insults in both in-vitro and animal models including 
experimental glaucoma. Under "normal" conditions, these channels participate in the 
transmission of excitatory signals between neurons in the retina and central visual 
pathways. Under pathological conditions, overactivity of these same channels may result in 
elevation of intracellular sodium concentration, loss of the electrochemical transmembrane 
gradient for sodium ions, decreased calcium extrusion via the sodium/calcium exchanger, 
elevation of intracellular calcium, and activation of calcium dependent intracellular 
mechanisms for RGC injury. 
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